最新ニュース Equifax (NYSE:EFX) 株価情報

Equifax

Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.

Equifax Inc

Effect Network

Enerflex Ltd

WIIM

Equifax shares are trading lower after Wells Fargo cut its price target on the stock from $321 to $313.

Wells Fargo analyst Jason Haas maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Overweight and lowers the price target from $321 to $313.

News

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on Equifax, Lowers Price Target to $313

In the last three months, 8 analysts have published ratings on Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>), offering a diverse range of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Equifax and provided 12-month price targets. The average target is $301.88, accompanied by a high estimate of $321.00 and a low estimate of $283.00. This current average has decreased by 3.24% from the previous average price target of $312.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1738098013_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
A comprehensive examination of how financial experts perceive Equifax is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Toni Kaplan</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$316.00</td>
<td>$320.00</td>
</tr>
<tr>
<td>Surinder Thind</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$300.00</td>
<td>$340.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$321.00</td>
<td>$325.00</td>
</tr>
<tr>
<td>Andy Grobler</td>
<td>Exane BNP Paribas</td>
<td>Announces</td>
<td>Outperform</td>
<td>$305.00</td>
<td>-</td>
</tr>
<tr>
<td>Toni Kaplan</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$320.00</td>
<td>$275.00</td>
</tr>
<tr>
<td>Shlomo Rosenbaum</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$284.00</td>
<td>$305.00</td>
</tr>
<tr>
<td>Andrew Steinerman</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$283.00</td>
<td>$304.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$286.00</td>
<td>$315.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Equifax. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Equifax compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Equifax's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into Equifax's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/EFX/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Equifax analyst ratings.</a>
<h2>Unveiling the Story Behind Equifax</h2>
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.
<h3>Financial Milestones: Equifax's Journey</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Positive Revenue Trend: Examining Equifax's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 9.3% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 9.8%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Equifax's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.94%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Equifax's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 1.15%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Equifax's debt-to-equity ratio is below the industry average. With a ratio of 1.11, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into Equifax Stock: Analyst Perspectives (8 Ratings)

Morgan Stanley analyst Toni Kaplan maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Overweight and lowers the price target from $320 to $316.

Morgan Stanley Maintains Overweight on Equifax, Lowers Price Target to $316

The Consumer Financial Protection Bureau (CFPB) has taken <a target="_blank" href="https://www.consumerfinance.gov/about-us/newsroom/cfpb-orders-equifax-to-pay-15-million-for-improper-investigations-of-credit-reporting-errors/" rel="noreferrer noopener">action </a>against Equifax Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>), a consumer reporting agency, for failing to properly investigate consumer disputes.
The CFPB&#8217;s investigation found that Equifax negatively impacted consumers by failing to fully investigate disputes, allowing previously removed errors to reappear, and using defective software that resulted in incorrect credit scores and inaccurate data being shared with lenders.
As a result, the order requires Equifax to follow federal regulations and pay a $15 million civil penalty, which will be directed to the CFPB&#8217;s victims relief fund.
The company handles a large volume of disputes monthly but fell short of meeting the legal requirements of the Fair Credit Reporting Act (FCRA).
The Act mandates consumer reporting agencies to investigate the accuracy of disputed information and take steps to ensure consumers&#8217; credit reports are accurate. 
Also Read: <a target="_blank" href="https://www.benzinga.com/news/global/25/01/43038940/bp-slashes-workforce-by-5-to-reach-2-billion-in-savings-goal" rel="noreferrer noopener">BP Slashes Workforce By 5% To Reach $2 Billion In Savings Goal</a>
The CFPB pointed out that Equifax reported credit information that it should have blocked because the information resulted from identity theft.
&#8220;Equifax failed in its basic duty to investigate and resolve consumer disputes about inaccurate information on their credit reports,&#8221; said CFPB Director Rohit Chopra.&nbsp;
&#8220;Today&#8217;s order requires Equifax to pay a civil penalty and follow federal laws on handling credit reporting disputes.&#8221;
Price Action: EFX shares are trading higher by 0.34% at $265.14 at the last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43054519/zyn-nicotine-pouches-receive-fda-marketing-approval" target="_blank" rel="noreferrer noopener">ZYN Nicotine Pouches Receive FDA Marketing Approval</a></li>
</ul>

Equities

Government

General

Equifax Fined $15M For Consumer Dispute Failures

<a href="https://www.consumerfinance.gov/about-us/newsroom/cfpb-orders-equifax-to-pay-15-million-for-improper-investigations-of-credit-reporting-errors/" title="https://www.consumerfinance.gov/about-us/newsroom/cfpb-orders-equifax-to-pay-15-million-for-improper-investigations-of-credit-reporting-errors/">https://www.consumerfinance.gov/about-us/newsroom/cfpb-orders-equifax-to-pay-15-million-for-improper-investigations-of-credit-reporting-errors/</a>

Legal

CFPB Orders Equifax To Pay $15M For Improper Investigations Of Credit Reporting Errors

Jefferies analyst Surinder Thind maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Buy and lowers the price target from $340 to $300.

Jefferies Maintains Buy on Equifax, Lowers Price Target to $300

Wells Fargo analyst Jason Haas maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Overweight and lowers the price target from $325 to $321.

Wells Fargo Maintains Overweight on Equifax, Lowers Price Target to $321

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>EOSE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.00</td>
<td>$97.4K</td>
<td>24.1K</td>
<td>5.0K</td>
</tr>
<tr>
<td>RTX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$120.00</td>
<td>$98.0K</td>
<td>2.3K</td>
<td>238</td>
</tr>
<tr>
<td>UBER</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$60.00</td>
<td>$79.3K</td>
<td>2.8K</td>
<td>176</td>
</tr>
<tr>
<td>LMT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$490.00</td>
<td>$494.8K</td>
<td>83</td>
<td>110</td>
</tr>
<tr>
<td>PWR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$310.00</td>
<td>$33.6K</td>
<td>657</td>
<td>68</td>
</tr>
<tr>
<td>BA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$165.00</td>
<td>$52.9K</td>
<td>675</td>
<td>54</td>
</tr>
<tr>
<td>UAL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$97.50</td>
<td>$28.2K</td>
<td>618</td>
<td>47</td>
</tr>
<tr>
<td>AXON</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$560.00</td>
<td>$160.0K</td>
<td>151</td>
<td>43</td>
</tr>
<tr>
<td>FDX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$280.00</td>
<td>$37.2K</td>
<td>176</td>
<td>34</td>
</tr>
<tr>
<td>EFX</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>07/18/25</td>
<td>$270.00</td>
<td>$40.7K</td>
<td>6</td>
<td>24</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For EOSE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOSE#NASDAQ">EOSE</a>), we notice a call option sweep that happens to be bearish, expiring in 379 day(s) on January 16, 2026. This event was a transfer of 221 contract(s) at a $1.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $97.4K, with a price of $441.0 per contract. There were 24135 open contracts at this strike prior to today, and today 5071 contract(s) were bought and sold. 
• Regarding RTX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>), we observe a put option sweep with bearish sentiment. It expires in 50 day(s) on February 21, 2025. Parties traded 157 contract(s) at a $120.00 strike. This particular put needed to be split into 37 different trades to become filled. The total cost received by the writing party (or parties) was $98.0K, with a price of $625.0 per contract. There were 2373 open contracts at this strike prior to today, and today 238 contract(s) were bought and sold. 
• For UBER (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>), we notice a call option sweep that happens to be bullish, expiring in 379 day(s) on January 16, 2026. This event was a transfer of 61 contract(s) at a $60.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $79.3K, with a price of $1300.0 per contract. There were 2896 open contracts at this strike prior to today, and today 176 contract(s) were bought and sold. 
• Regarding LMT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>), we observe a call option trade with bullish sentiment. It expires in 379 day(s) on January 16, 2026. Parties traded 109 contract(s) at a $490.00 strike. The total cost received by the writing party (or parties) was $494.8K, with a price of $4540.0 per contract. There were 83 open contracts at this strike prior to today, and today 110 contract(s) were bought and sold. 
• For PWR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PWR#NYSE">PWR</a>), we notice a put option trade that happens to be bullish, expiring in 15 day(s) on January 17, 2025. This event was a transfer of 59 contract(s) at a $310.00 strike. The total cost received by the writing party (or parties) was $33.6K, with a price of $570.0 per contract. There were 657 open contracts at this strike prior to today, and today 68 contract(s) were bought and sold. 
• Regarding BA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>), we observe a call option sweep with bearish sentiment. It expires in 105 day(s) on April 17, 2025. Parties traded 30 contract(s) at a $165.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $52.9K, with a price of $1765.0 per contract. There were 675 open contracts at this strike prior to today, and today 54 contract(s) were bought and sold. 
• Regarding UAL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>), we observe a put option trade with bearish sentiment. It expires in 50 day(s) on February 21, 2025. Parties traded 34 contract(s) at a $97.50 strike. The total cost received by the writing party (or parties) was $28.2K, with a price of $830.0 per contract. There were 618 open contracts at this strike prior to today, and today 47 contract(s) were bought and sold. 
• For AXON (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXON#NASDAQ">AXON</a>), we notice a call option trade that happens to be bearish, expiring in 15 day(s) on January 17, 2025. This event was a transfer of 40 contract(s) at a $560.00 strike. The total cost received by the writing party (or parties) was $160.0K, with a price of $4000.0 per contract. There were 151 open contracts at this strike prior to today, and today 43 contract(s) were bought and sold. 
• For FDX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>), we notice a call option trade that happens to be bullish, expiring in 379 day(s) on January 16, 2026. This event was a transfer of 11 contract(s) at a $280.00 strike. The total cost received by the writing party (or parties) was $37.2K, with a price of $3390.0 per contract. There were 176 open contracts at this strike prior to today, and today 34 contract(s) were bought and sold. 
• Regarding EFX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>), we observe a call option trade with neutral sentiment. It expires in 197 day(s) on July 18, 2025. Parties traded 24 contract(s) at a $270.00 strike. The total cost received by the writing party (or parties) was $40.7K, with a price of $1699.0 per contract. There were 6 open contracts at this strike prior to today, and today 24 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

AXON

EOSE

UBER

10 Industrials Stocks Whale Activity In Today's Session

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>B of A Securities analyst Andrew Obin upgraded the rating for AMETEK, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) from Neutral to Buy and raised the price target from $195 to $225. AMETEK shares closed at $187.38 on Friday. See how other analysts view this stock.</li>
<li>JP Morgan analyst Samik Chatterjee upgraded NetApp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTAP#NASDAQ">NTAP</a>) from Neutral to Overweight and announced a $160 price target. NetApp shares closed at $121.95 on Friday. <a href="https://www.benzinga.com/quote/NTAP/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Gordon Haskett analyst Chuck Grom upgraded the rating for Macy&#8217;s, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/M#NYSE">M</a>) from Hold to Buy and announced a $20 price target. Macy&#8217;s shares closed at $16.56 on Friday. See how other analysts view this stock.</li>
<li>Mizuho analyst Nitin Kumar upgraded ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>) from Neutral to Outperform and boosted the price target from $132 to $134. ConocoPhillips shares closed at $101.02 on Friday. <a href="https://www.benzinga.com/quote/COP/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Exane BNP Paribas analyst Andy Grobler upgraded the rating for Equifax Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) from Neutral to Outperform and announced a $305 price target. Equifax shares closed at $265.81 on Friday. <a href="https://www.benzinga.com/quote/EFX/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying COP stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="582" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16070350/image-122-1024x582.png" alt="" class="wp-image-693623" style="width:616px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16070350/image-122-1024x582.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16070350/image-122-300x170.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16070350/image-122-768x436.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16070350/image-122.png 1132w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42482639/wall-streets-most-accurate-analysts-give-their-take-on-3-energy-stocks-with-over-6-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Energy Stocks With Over 6% Dividend Yields</a></li>
</ul>

Upgrades

Pre-Market Outlook

Markets

Trading Ideas

NTAP

This ConocoPhillips Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

Exane BNP Paribas analyst Andy Grobler upgrades Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) from Neutral to Outperform and announces $305 price target.

Exane BNP Paribas Upgrades Equifax to Outperform, Announces $305 Price Target

In the preceding three months, 12 analysts have released ratings for Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>), presenting a wide array of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">8</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $325.83, with a high estimate of $375.00 and a low estimate of $283.00. This upward trend is evident, with the current average reflecting a 2.29% increase from the previous average price target of $318.55.
<img src="https://www.benzinga.com/files/images/story/2024/1734004858_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The perception of Equifax by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Toni Kaplan</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$320.00</td>
<td>$275.00</td>
</tr>
<tr>
<td>Shlomo Rosenbaum</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$284.00</td>
<td>$305.00</td>
</tr>
<tr>
<td>Andrew Steinerman</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$283.00</td>
<td>$304.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$286.00</td>
<td>$315.00</td>
</tr>
<tr>
<td>Kyle Peterson</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$350.00</td>
<td>$350.00</td>
</tr>
<tr>
<td>Jeffrey Meuler</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$333.00</td>
<td>$290.00</td>
</tr>
<tr>
<td>Andrew Steinerman</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$304.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$350.00</td>
<td>$375.00</td>
</tr>
<tr>
<td>Kyle Peterson</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$350.00</td>
<td>$350.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$315.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$375.00</td>
<td>$340.00</td>
</tr>
<tr>
<td>Kevin Mcveigh</td>
<td>UBS</td>
<td>Announces</td>
<td>Buy</td>
<td>$360.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Equifax. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Equifax compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Equifax's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Equifax's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EFX/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Equifax analyst ratings.</a>
<h2>About Equifax</h2>
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.
<h3>Financial Insights: Equifax</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: Equifax's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 9.3%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: Equifax's net margin is impressive, surpassing industry averages. With a net margin of 9.8%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Equifax's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.94%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Equifax's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 1.15%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.11.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

In-Depth Examination Of 12 Analyst Recommendations For Equifax

Morgan Stanley analyst Toni Kaplan upgrades Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) from Equal-Weight to Overweight and raises the price target from $275 to $320.

Morgan Stanley Upgrades Equifax to Overweight, Raises Price Target to $320

Wolfe Research analyst Scott Wurtzel downgrades Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) from Outperform to Peer Perform.

Downgrades

Wolfe Research Downgrades Equifax to Peer Perform

On Thursday, Equifax, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) announced it partnered with Mastercard Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) to help Latin American financial institutions, payment service providers, acquiring banks, <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/n42351562/equifax-and-mastercard-join-forces-to-combat-payment-fraud-in-latin-america" rel="noreferrer noopener">and merchants tackle payment fraud</a>.
Mastercard business customers in Latin America will now have access to enhanced fraud management tools, including Mastercard Identity, Ethoca Alerts, and Ethoca Consumer Clarity, through Equifax's Kount Payment Fraud solution.
These integrated solutions safeguard the digital payments ecosystem with identity verification, fraud risk assessment, and chargeback prevention via order validation and alerting services.
Equifax's Kount Payment Fraud solution and Mastercard are expected to help businesses stop threats in real time to drive growth and protect revenue.
Chris Jones, President of Equifax Latin America, stated, "This strategic alignment will provide safer payment transactions and reduce chargebacks, enabling businesses of all sizes in&nbsp;Latin America&nbsp;to improve their bottom line."
"Adding to our existing capabilities, this collaboration is the next step in our journey to make the digital economy safe and more seamless for payment providers and merchants in the region," said&nbsp;Ana Lucia Magliano, Executive Vice President of services, Mastercard Latin America and the&nbsp;Caribbean.
Notably, according to a merchant-savvy report, Latin America, where merchants lose over 4.6% of e-commerce revenue to fraud, is set to see e-commerce nearly double to $160 billion by 2025.
Investors can gain exposure to the EFX via Virtus ETF Trust II Virtus KAR Mid-Cap ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMID#NYSE">KMID</a>) and Fidelity Disruptive Finance ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDFF#NASDAQ">FDFF</a>).
Price Action: EFX shares are up 0.22% to $261.35 premarket at the last check on Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/24/12/42321510/mastercard-settles-uk-antitrust-lawsuit-for-250-million" target="_blank" rel="noreferrer noopener">Mastercard Settles UK Antitrust Lawsuit For $250 Million</a></li>
</ul>

Large Cap

Contracts

FDFF

Virtus ETF Trust II Virtus KAR Mid-Cap ETF

KMID

Latin America's $160 Billion E-Commerce Market Gets a Security Boost with Equifax and Mastercard Alliance

Equifax And Mastercard Partner To Launch Kount Payment Fraud Prevention And Chargeback Mitigation Solutions In Latin America, Enhancing Fraud Management For Financial Institutions And Merchants

EXPGY

U.S. Consumer Financial Protection Bureau Is Moving Ahead With Rulemaking In Final Weeks Of Biden Administration; Intends To Finalize Rule Removing Medical Debt From Credit Reports, Propose New Restrictions On Data Brokers, Source Says

Equifax's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) short percent of float has risen 13.1% since its last report. The company recently reported that it has 2.48 million shares sold short, which is 2.59% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.3 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Equifax Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732216515_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Equifax has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Equifax's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Equifax's peer group average for short interest as a percentage of float is 2.94%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Equifax?

JP Morgan analyst Andrew Steinerman maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Overweight and lowers the price target from $304 to $283.

JP Morgan Maintains Overweight on Equifax, Lowers Price Target to $283

Oppenheimer analyst Owen Lau maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Outperform and lowers the price target from $315 to $286.

Oppenheimer Maintains Outperform on Equifax, Lowers Price Target to $286

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new B...

3 Best Stocks to Buy Now, 1/6/2025, According to Top Analysts

The 'New Equifax' Will Be More Profitable On New Cloud

Wells Fargo analyst Jason Haas CFA assigned a Buy rating to Equifax (EFX – Research Report) today and set a price target of $321.00. The company's ...

Wells Fargo Gives a Buy Rating to Equifax (EFX)

Oakmark Select Fund Q4 2024 Commentary

Oakmark Equity And Income Fund Q4 2024 Commentary

Equifax fined $15M by CFPB for inadequate investigations of credit reporting errors

Analysts fell to the sidelines weighing in on Equifax (EFX – Research Report) and Trane Technologies (TT – Research Report) with neutral ratings, i...

Analysts Offer Insights on Industrial Goods Companies: Equifax (EFX) and Trane Technologies (TT)

Companies in the Industrial Goods sector have received a lot of coverage today as analysts weigh in on Equifax (EFX – Research Report), Eaton (ETN ...

Analysts Offer Insights on Industrial Goods Companies: Equifax (EFX), Eaton (ETN) and CSX (CSX)

Morgan Stanley lowered the firm's price target on Equifax (EFX) to $316 from $320 and keeps an Overweight rating on the shares. While the firm expe...

Comments

Equifax

ニュース

最新ニュース Equifax (NYSE:EFX) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル